Issue 4/2006
Content (11 Articles)
The Burden of Age-Related Macular Degeneration
Jordana K. Schmier, Mechelle L. Jones, Michael T. Halpern
Economic and Developmental Considerations for Pharmacogenomic Technology
John A. Vernon, Scott J. Johnson, W. Keener Hughen, Antonio Trujillo
Optimal Assignment of Treatments to Health States Using a Markov Decision Model
Mohan V. Bala, Josephine A. Mauskopf
Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment
Zoë Philips, Laura Bojke, Mark Sculpher, Karl Claxton, Su Golder
Post-Exposure Influenza Prophylaxis with Oseltamivir
Beate Sander, Frederick G. Hayden, Marlene Gyldmark, Louis P. Garrison Jr
A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy
Aslam H. Anis, Huiying Sun, Sonia Singh, John Woolcott, Bohdan Nosyk, Marc Brisson
Productivity Costs in Health-State Valuations
Marieke Krol, Werner Brouwer, Pedram Sendi
Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women
Stephanie Land
The Authors’ Reply
Richard J. Milne, Kathy H. Heaton-Brown, Paul Hansen, David Thomas, Vernon Harvey, Alison Cubitt